Raven joined SV Health Investors in 2017.
Prior to joining SV, Raven completed his PhD in Biological Engineering at the Koch Institute for Integrative Cancer Research at MIT. His thesis work focused on measuring cellular signaling dynamics with high temporal resolution to uncover novel biology in the EGFR network. While at MIT, he was also part of the founding team of the MIT Biotechnology Group, a student organization focused on exposing academic trainees to the world of industrial biotechnology. Through MBG, he developed a novel program, Research Experiences in Biopharma, which allowed PhD candidates to conduct part-time research with local companies including Novartis, Pfizer and Amgen.
BS, Biological Engineering, MIT; PhD, Biological Engineering, MIT
Outside of SV
Raven keeps involved with the MIT Biotechnology Group as an advisor, and is an active alum of the MIT Golf Team.